Pulse Biosciences, Inc. (PLSE) stock
PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$44.84−1.52 (-3.28%)
Close on Nov 17, 2026Market cap $3.20BP/E –Yield –
Pulse Biosciences cash
Cash and short-term investments held at the end of each period.
Pulse Biosciences's cash was $101.62M at Jun 30, 2026. For fiscal 2025 it was $80.74M, down 31.6% from the year before. Over ten years it grew 36.5% a year on average. The highest annual figure on record is $118.04M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $80.74M | -31.6% |
| FY2024 | Dec 31, 2024 | $118.04M | +166.1% |
| FY2023 | Dec 31, 2023 | $44.37M | -27.4% |
| FY2022 | Dec 31, 2022 | $61.14M | +113.8% |
| FY2021 | Dec 31, 2021 | $28.60M | +39.7% |
| FY2020 | Dec 31, 2020 | $20.48M | +196.8% |
| FY2019 | Dec 31, 2019 | $6.90M | -88.4% |
| FY2018 | Dec 31, 2018 | $59.58M | +56.5% |
| FY2017 | Dec 31, 2017 | $38.07M | +132.2% |
| FY2016 | Dec 31, 2016 | $16.40M | +354.7% |
| FY2015 | Dec 31, 2015 | $3.61M | -48.6% |
| FY2014 | Dec 31, 2014 | $7.01M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $101.62M | -4.4% |
| Q1 FY2026 | Mar 31, 2026 | $68.32M | -42.7% |
| Q4 FY2025 | Dec 31, 2025 | $80.74M | -31.6% |
| Q3 FY2025 | Sep 30, 2025 | $95.21M | +20.5% |
| Q2 FY2025 | Jun 30, 2025 | $106.35M | +306.0% |
| Q1 FY2025 | Mar 31, 2025 | $119.28M | +241.9% |
| Q4 FY2024 | Dec 31, 2024 | $118.04M | +166.1% |
| Q3 FY2024 | Sep 30, 2024 | $79.03M | +56.9% |
| Q2 FY2024 | Jun 30, 2024 | $26.20M | -55.4% |
| Q1 FY2024 | Mar 31, 2024 | $34.89M | -35.5% |
| Q4 FY2023 | Dec 31, 2023 | $44.37M | -27.4% |
| Q3 FY2023 | Sep 30, 2023 | $50.39M | -27.1% |
| Q2 FY2023 | Jun 30, 2023 | $58.75M | +296.9% |
| Q1 FY2023 | Mar 31, 2023 | $54.10M | +326.0% |
| Q4 FY2022 | Dec 31, 2022 | $61.14M | +113.8% |
| Q3 FY2022 | Sep 30, 2022 | $69.16M | +64.7% |
| Q2 FY2022 | Jun 30, 2022 | $14.80M | -68.8% |
| Q1 FY2022 | Mar 31, 2022 | $12.70M | -78.8% |
| Q4 FY2021 | Dec 31, 2021 | $28.60M | +39.7% |
| Q3 FY2021 | Sep 30, 2021 | $42.00M | +41.9% |
| Q2 FY2021 | Jun 30, 2021 | $47.43M | +25.6% |
| Q1 FY2021 | Mar 31, 2021 | $59.88M | +276.6% |
| Q4 FY2020 | Dec 31, 2020 | $20.48M | +196.8% |
| Q3 FY2020 | Sep 30, 2020 | $29.60M | -14.2% |
| Q2 FY2020 | Jun 30, 2020 | $37.77M | -11.4% |
| Q1 FY2020 | Mar 31, 2020 | $15.90M | -69.9% |
| Q4 FY2019 | Dec 31, 2019 | $6.90M | -88.4% |
| Q3 FY2019 | Sep 30, 2019 | $34.50M | +64.1% |
| Q2 FY2019 | Jun 30, 2019 | $42.64M | +55.1% |
| Q1 FY2019 | Mar 31, 2019 | $52.80M | +58.2% |
| Q4 FY2018 | Dec 31, 2018 | $59.58M | +56.5% |
| Q3 FY2018 | Sep 30, 2018 | $21.02M | -50.0% |
| Q2 FY2018 | Jun 30, 2018 | $27.50M | +78.6% |
| Q1 FY2018 | Mar 31, 2018 | $33.38M | +77.0% |
| Q4 FY2017 | Dec 31, 2017 | $38.07M | +132.2% |
| Q3 FY2017 | Sep 30, 2017 | $42.04M | +124.7% |
| Q2 FY2017 | Jun 30, 2017 | $15.40M | – |
| Q1 FY2017 | Mar 31, 2017 | $18.86M | – |
| Q4 FY2016 | Dec 31, 2016 | $16.40M | – |
| Q3 FY2016 | Sep 30, 2016 | $18.71M | – |
See a number that looks wrong?